173 related articles for article (PubMed ID: 17952116)
21. Promoter-specific transcription of insulin-like growth factor-II in epithelial ovarian cancer.
Lu L; Katsaros D; Wiley A; Rigault de la Longrais IA; Puopolo M; Schwartz P; Yu H
Gynecol Oncol; 2006 Dec; 103(3):990-5. PubMed ID: 16859738
[TBL] [Abstract][Full Text] [Related]
22. Differential gene expression signature between primary and metastatic head and neck squamous cell carcinoma.
Liu CJ; Liu TY; Kuo LT; Cheng HW; Chu TH; Chang KW; Lin SC
J Pathol; 2008 Mar; 214(4):489-97. PubMed ID: 18213732
[TBL] [Abstract][Full Text] [Related]
23. A colorectal cancer expression profile that includes transforming growth factor beta inhibitor BAMBI predicts metastatic potential.
Fritzmann J; Morkel M; Besser D; Budczies J; Kosel F; Brembeck FH; Stein U; Fichtner I; Schlag PM; Birchmeier W
Gastroenterology; 2009 Jul; 137(1):165-75. PubMed ID: 19328798
[TBL] [Abstract][Full Text] [Related]
24. Gene expression profiling of paired ovarian tumors obtained prior to and following adjuvant chemotherapy: molecular signatures of chemoresistant tumors.
L'Espérance S; Popa I; Bachvarova M; Plante M; Patten N; Wu L; Têtu B; Bachvarov D
Int J Oncol; 2006 Jul; 29(1):5-24. PubMed ID: 16773180
[TBL] [Abstract][Full Text] [Related]
25. Effects of raf kinase inhibitor protein expression on metastasis and progression of human epithelial ovarian cancer.
Li HZ; Wang Y; Gao Y; Shao J; Zhao XL; Deng WM; Liu YX; Yang J; Yao Z
Mol Cancer Res; 2008 Jun; 6(6):917-28. PubMed ID: 18567796
[TBL] [Abstract][Full Text] [Related]
26. IGF axis gene expression patterns are prognostic of survival in epithelial ovarian cancer.
Spentzos D; Cannistra SA; Grall F; Levine DA; Pillay K; Libermann TA; Mantzoros CS
Endocr Relat Cancer; 2007 Sep; 14(3):781-90. PubMed ID: 17914107
[TBL] [Abstract][Full Text] [Related]
27. Overexpression of CHP2 enhances tumor cell growth, invasion and metastasis in ovarian cancer.
Jin Q; Kong B; Yang X; Cui B; Wei Y; Yang Q
In Vivo; 2007; 21(4):593-8. PubMed ID: 17708351
[TBL] [Abstract][Full Text] [Related]
28. Characterization of LMX-1A as a metastasis suppressor in cervical cancer.
Liu CY; Chao TK; Su PH; Lee HY; Shih YL; Su HY; Chu TY; Yu MH; Lin YW; Lai HC
J Pathol; 2009 Oct; 219(2):222-31. PubMed ID: 19644956
[TBL] [Abstract][Full Text] [Related]
29. ASPM is a novel marker for vascular invasion, early recurrence, and poor prognosis of hepatocellular carcinoma.
Lin SY; Pan HW; Liu SH; Jeng YM; Hu FC; Peng SY; Lai PL; Hsu HC
Clin Cancer Res; 2008 Aug; 14(15):4814-20. PubMed ID: 18676753
[TBL] [Abstract][Full Text] [Related]
30. Maspin overexpression correlates with increased expression of vascular endothelial growth factors A, C, and D in human ovarian carcinoma.
Bolat F; Gumurdulu D; Erkanli S; Kayaselcuk F; Zeren H; Ali Vardar M; Kuscu E
Pathol Res Pract; 2008; 204(6):379-87. PubMed ID: 18343598
[TBL] [Abstract][Full Text] [Related]
31. Insulin-like growth factor binding protein-5 (IGFBP-5) suppresses the tumourigenesis of head and neck squamous cell carcinoma.
Hung PS; Kao SY; Shih YH; Chiou SH; Liu CJ; Chang KW; Lin SC
J Pathol; 2008 Feb; 214(3):368-76. PubMed ID: 18085517
[TBL] [Abstract][Full Text] [Related]
32. Estrogen and progestin regulate metastasis through the PI3K/AKT pathway in human ovarian cancer.
Hua K; Feng W; Cao Q; Zhou X; Lu X; Feng Y
Int J Oncol; 2008 Nov; 33(5):959-67. PubMed ID: 18949358
[TBL] [Abstract][Full Text] [Related]
33. Use of gene expression profiles to stage concurrent endometrioid tumors of the endometrium and ovary.
Guirguis A; Elishaev E; Oh SH; Tseng GC; Zorn K; DeLoia JA
Gynecol Oncol; 2008 Feb; 108(2):370-6. PubMed ID: 18083218
[TBL] [Abstract][Full Text] [Related]
34. Functional and clinical evidence for NDRG2 as a candidate suppressor of liver cancer metastasis.
Lee DC; Kang YK; Kim WH; Jang YJ; Kim DJ; Park IY; Sohn BH; Sohn HA; Lee HG; Lim JS; Kim JW; Song EY; Kim DM; Lee MN; Oh GT; Kim SJ; Park KC; Yoo HS; Choi JY; Yeom YI
Cancer Res; 2008 Jun; 68(11):4210-20. PubMed ID: 18519680
[TBL] [Abstract][Full Text] [Related]
35. Gene expression profile of ovarian serous papillary carcinomas: identification of metastasis-associated genes.
Bignotti E; Tassi RA; Calza S; Ravaggi A; Bandiera E; Rossi E; Donzelli C; Pasinetti B; Pecorelli S; Santin AD
Am J Obstet Gynecol; 2007 Mar; 196(3):245.e1-11. PubMed ID: 17346539
[TBL] [Abstract][Full Text] [Related]
36. An inhibitory effect of miR-22 on cell migration and invasion in ovarian cancer.
Li J; Liang S; Yu H; Zhang J; Ma D; Lu X
Gynecol Oncol; 2010 Dec; 119(3):543-8. PubMed ID: 20869762
[TBL] [Abstract][Full Text] [Related]
37. Insulin-like growth factor-binding protein-5 (IGFBP-5) acts as a tumor suppressor by inhibiting angiogenesis.
Rho SB; Dong SM; Kang S; Seo SS; Yoo CW; Lee DO; Woo JS; Park SY
Carcinogenesis; 2008 Nov; 29(11):2106-11. PubMed ID: 18775916
[TBL] [Abstract][Full Text] [Related]
38. Screening of the metastasis-associated genes by gene chip in high metastatic human ovarian cancer cell lines.
Xu S; Mou H; Gu L; Su D; Zhu C; Liu X
J Genet Genomics; 2007 Jul; 34(7):581-90. PubMed ID: 17643943
[TBL] [Abstract][Full Text] [Related]
39. Diagnostic and prognostic role of the insulin growth factor pathway members insulin-like growth factor-II and insulin-like growth factor binding protein-3 in serous effusions.
Slipicevic A; Øy GF; Askildt IC; Holth A; Hellesylt E; Flørenes VA; Davidson B
Hum Pathol; 2009 Apr; 40(4):527-37. PubMed ID: 19121847
[TBL] [Abstract][Full Text] [Related]
40. Vascular endothelial growth factor D and intratumoral lymphatics as independent prognostic factors in epithelial ovarian carcinoma.
Li L; Liu B; Li X; Yang S; Xiao J; Chen M; Zhang Y; Ma J
Anat Rec (Hoboken); 2009 Apr; 292(4):562-9. PubMed ID: 19226617
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]